NCT06462833 Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis
| NCT ID | NCT06462833 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gazi University |
| Condition | Osteoporosis, Postmenopausal |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2024-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-07-01 with a primary completion date of 2024-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postmenopausal osteoporosis is characterized by low bone mass and increased fracture risk. Treatment includes exercise, nutrition, supplements, and medications like bisphosphonates, denosumab, or hormone replacement therapy. Lifestyle changes such as quitting smoking, reducing alcohol consumption, and preventing falls are also crucial. Despite effective treatments, adherence is low: 20-30% of patients don't start oral bisphosphonates, and 16-60% continue medications after one year. Exercise adherence rates are similarly low (14.3%-57.7%). This non-adherence imposes a significant clinical and economic burden. Health literacy (HL)-the ability to find, understand, and use health information-is vital for managing health but is understudied in relation to osteoporosis treatment adherence. This study aims to examine the relationship between HL, exercise habits, and medication adherence in postmenopausal osteoporosis patients. Understanding these factors can lead to effective interventions, improving patient adherence and health outcomes. The study will measure HL levels and their correlation with medication and exercise adherence, potentially informing health education programs and strategies to enhance treatment adherence. By doing so, it aims to improve health outcomes and healthcare system efficiency.
Eligibility Criteria
Inclusion Criteria: * Postmenopausal patients * Being under outpatient follow-up for osteoporosis for at least one year Exclusion Criteria: * Orthopedic, rheumatic, and neurological conditions that may hinder participation in exercise * Cancer * Refusal to participate in the study
Contact & Investigator
Ayça Utkan Karasu, MD
PRINCIPAL INVESTIGATOR
Gazi University
Frequently Asked Questions
Who can join the NCT06462833 clinical trial?
This trial is open to female participants only, aged 45 Years or older, studying Osteoporosis, Postmenopausal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06462833 currently recruiting?
Yes, NCT06462833 is actively recruiting participants. Contact the research team at aycautkan@gazi.edu.tr for enrollment information.
Where is the NCT06462833 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06462833 clinical trial?
NCT06462833 is sponsored by Gazi University. The principal investigator is Ayça Utkan Karasu, MD at Gazi University. The trial plans to enroll 60 participants.